Centro de Atención e Investigación en Factores de Riesgo Car
Mexico, Distrito Federal, Mexico
Hospital in Mexico City
Av. Insurgentes Sur 4126, Tlalpan Centro II, Tlalpan, 14000 Ciudad de México, CDMX
About Centro de Atención e Investigación en Factores de Riesgo Car
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Allergan
2
Clinical Trials at Centro de Atención e Investigación en Factores de Riesgo Car
During the past decade, Centro de Atención e Investigación en Factores de Riesgo Car conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
2018-02-01
2020-11-05
Terminated
450
Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02
2018-02-16
2020-07-16
Terminated
311
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Centro de Atención e Investigación en Factores de Riesgo Car
According to Clinical.Site data, the most researched conditions in "Centro de Atención e Investigación en Factores de Riesgo Car" are
"Diabetes Mellitus" (2 trials) and "Gastroparesis" (2 trials). Many other conditions were trialed in "Centro de Atención e Investigación en Factores de Riesgo Car" in a lesser frequency.
Clinical Trials Intervention Types at Centro de Atención e Investigación en Factores de Riesgo Car
Most popular intervention types in "Centro de Atención e Investigación en Factores de Riesgo Car" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials) and "Relamorelin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Centro de Atención e Investigación en Factores de Riesgo Car
The vast majority of trials in "Centro de Atención e Investigación en Factores de Riesgo Car" are
2 trials for "All" genders.
Clinical Trials Status at Centro de Atención e Investigación en Factores de Riesgo Car
Currently, there are NaN active trials in "Centro de Atención e Investigación en Factores de Riesgo Car".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Centro de Atención e Investigación en Factores de Riesgo Car,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Centro de Atención e Investigación en Factores de Riesgo Car, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".